美国PSA筛查合格人群中前列腺癌结局的种族差异
在PSA筛查合格年龄组(55-69岁)中,黑种人转移(AOR 1.76 vs 1.55,P交互<0.001)和PCSM(AHR 1.53 vs 1.25,P交互=0.01)的种族差异较非合格组更显著。
要点
- 黑种人前列腺癌患者转移风险(AOR 1.65)和PCSM风险(AHR 1.36)均高于非黑种人。
- PSA筛查合格组(55-69岁)中黑种人转移(AOR 1.76)和PCSM(AHR 1.53)的种族差异大于非合格组。
- 作者认为黑种人种族应纳入更新的USPSTF PSA筛查指南。
核心结论
- 黑种人前列腺癌结局的种族差异在PSA筛查合格人群中显著更差。
- 作者认为黑种人可能受到美国结束PSA筛查建议的不成比例影响,并建议将黑种人种族纳入更新的USPSTF PSA筛查指南。
研究设计与样本
- 利用SEER数据库分析2004-2011年美国390 259例前列腺癌患者。
- 采用多变量logistic回归分析黑种人种族与分期presentation的关联。
- 采用Fine-Gray竞争风险回归分析黑种人种族与PCSM的关联,均以筛查合格性(55-69岁 vs 非合格)为函数。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In 2012, the United States Preventive Services Task Force (USPSTF) recommended against prostate-specific antigen (PSA) screening, despite evidence that Black men are at a higher risk of prostate cancer-specific mortality (PCSM). We evaluated whether Black men of potentially screening-eligible age (55-69 years) are at a disproportionally high risk of poor outcomes. PATIENTS AND METHODS: The SEER database was used to study 390 259 men diagnosed with prostate cancer in the United States between 2004 and 2011. Multivariable logistic regression modeled the association between Black race and stage of presentation, while Fine-Gray competing risks regression modeled the association between Black race and PCSM, both as a function of screening eligibility (age 55-69 years versus not). RESULTS: Black men were more likely to present with metastatic disease (adjusted odds ratio [AOR] 1.65; 1.58-1.72; P < 0.001) and were at a higher risk of PCSM (adjusted hazard ratio [AHR] 1.36; 1.27-1.46; P < 0.001) compared to non-Black men. There were significant interactions between race and PSA-screening eligibility such that Black patients experienced more disproportionate rates of metastatic disease (AOR 1.76; 1.65-1.87 versus 1.55; 1.47-1.65; Pinteraction < 0.001) and PCSM (AHR 1.53; 1.37-1.70 versus 1.25; 1.14-1.37; Pinteraction = 0.01) in the potentially PSA-screening eligible group than in the group not eligible for screening. CONCLUSIONS: Racial disparities in prostate cancer outcome among Black men are significantly worse in PSA-screening eligible populations. These results raise the possibility that Black men could be disproportionately impacted by recommendations to end PSA screening in the United States and suggest that Black race should be included in the updated USPSTF PSA screening guidelines.
引用
- Mahal BA, Chen YW, Muralidhar V, et al. Racial disparities in prostate cancer outcome among prostate-specific antigen screening eligible populations in the United States. Ann Oncol. 2017. PMID: 28453693. doi:10.1093/annonc/mdx041
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。